SCHEMBL7308253

SCHEMBL7308253

COc1ccc(P(=O)(OCC(=O)COP(=O)(c2ccccc2)c2ccc(OC)cc2)c2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACP3 P15309 1/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ RAB9A P51151 5/20 0.46
▸ NPC1 O15118 4/20 0.46
▸ CES2 O00748 1/20 0.45
▸ CES1 P23141 1/20 0.45
▸ HCAR2 Q8TDS4 1/20 0.45
▸ PTGS2 P35354 1/20 0.44
▸ POLB P06746 2/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ CTDSP1 Q9GZU7 1/20 0.44
▸ MAPK1 P28482 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ USP2 O75604 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ HIF1A Q16665 1/20 0.43
▸ PKM P14618 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7308021 0.87 LMNA (0.48) KMT2AMEN1RAB9ANPC1POLB
SCHEMBL3893770 0.87 MEN1 (0.55) KMT2AMEN1POLBALDH1A1GAA
SCHEMBL7304302 0.82 KMT2A (0.47) ACP3KMT2AMEN1RAB9ANPC1
SCHEMBL11614997 0.82 KMT2A (0.56) ACP3KMT2AMEN1RAB9ANPC1
SCHEMBL7303095 0.81 KMT2A (0.46) KMT2AMEN1RAB9ANPC1CES2
SCHEMBL28520294 0.79 RAB9A (0.52) ACP3KMT2AMEN1RAB9ANPC1
SCHEMBL31472733 0.78 PKM (0.54) ACP3KMT2AMEN1RAB9ANPC1
SCHEMBL8734179 0.78 POLB (0.60) ACP3RAB9ANPC1CES2CES1
SCHEMBL28445150 0.78 NPC1 (0.50) ACP3KMT2AMEN1RAB9ANPC1
SCHEMBL28441070 0.77 POLB (0.59) KMT2AMEN1POLBALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5843905-A Peptidic phosphinyloxymethyl ketones as interleukin-1β-converting enzyme inhibitors VERTEX PHARMACEUTICALS, INCORPORATED (US) 1998-12-01 — — US claimed
EP-0644197-B1 Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors VERTEX PHARMA (US) 1998-09-09 — — EP claimed
EP-0644197-A1 Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors STERLING WINTHROP INC. (US) 1995-03-22 — — EP claimed
US-5843905-A Peptidic phosphinyloxymethyl ketones as interleukin-1β-converting enzyme inhibitors VERTEX PHARMACEUTICALS, INCORPORATED (US) 1998-12-01 — — US disclosed
EP-0644197-B1 Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors VERTEX PHARMA (US) 1998-09-09 — — EP disclosed
EP-0644197-A1 Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors STERLING WINTHROP INC. (US) 1995-03-22 — — EP disclosed
Send feedback